(2-amino-3-chlorophenyl)(3-hydroxyphenyl)methanone | 1134338-45-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2-amino-3-chlorophenyl)(3-hydroxyphenyl)methanone
• 英文别名: (2-Amino-3-chlorophenyl)-(3-hydroxyphenyl)methanone
• CAS: 1134338-45-6
• 化学式: C₁₃H₁₀ClNO₂
• 分子量: 247.681
• InChiKey: CJLUEFZFIWQZTQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2-amino-3-chlorophenyl)(3-hydroxyphenyl)methanone 在 4-二甲氨基吡啶 硫酸 、 溶剂黄146 、 N,N'-二环己基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 66.0h， 生成 3-(8-chloro-3-isopropylquinolin-4-yl)phenyl 3-(ethylsulfonyl)benzoate
  参考文献：
  名称：

  NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS

  摘要：

  公开了式(I)的喹啉酯化合物，这些化合物可用作肝X受体（LXR）调节剂。还公开了含有式(I)的喹啉酯化合物的药物组合物，以及在安全治疗各种皮肤疾病中使用式(I)的喹啉酯化合物。进一步描述了制备和使用喹啉酯的方法。

  公开号：

  US20120010205A1
• 作为产物：
  描述：

  3-甲氧基苯腈 、 邻氯苯胺 在 三氯化硼 、 aluminum (III) chloride 、 盐酸 、 水 作用下， 以 二氯甲烷 、 氯苯 为溶剂， 反应 3.33h， 以37%的产率得到(2-amino-3-chlorophenyl)(3-hydroxyphenyl)methanone
  参考文献：
  名称：

  Biarylether amide quinolines as liver X receptor agonists

  摘要：

  A series of 4-(amido-biarylether)-quinolines was prepared as potential LXR agonists. Appropriate substitution with amide groups provided high affinity LXR ligands, some with excellent potency and efficacy in functional assays of LXR activity. Novel amide 4g had a binding IC50 = 1.9 nM for LXRb and EC50 = 34 nM (96% efficacy relative to T0901317) in an ABCA1 gene expression assay in mouse J774 cells, demonstrating that 4-(biarylether)-quinolines with appropriate amide substitution are potent LXR agonists (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2008.12.048

文献信息

• 4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists
  作者：Ronald C. Bernotas、David H. Kaufman、Robert R. Singhaus、John Ullrich、Rayomand Unwalla、Elaine Quinet、Ponnal Nambi、Anna Wilhelmsson、Annika Goos-Nilsson、Jay Wrobel

  DOI：10.1016/j.bmc.2009.10.001

  日期：2009.12

  A series of 4-(3-aryloxyaryl)quinolines with alcohol substituents on the terminal aryl ring was prepared as potential LXR agonists, in which an alcohol group replaced an amide in previously reported amide analogs. High affinity LXR ligands with excellent agonist potency and efficacy in a functional model of LXR activity were identified, demonstrating that alcohols can substitute for amides while retaining LXR activity. The most potent compound was 5b which had an IC50 = 3.3 nM for LXR beta binding and EC50 = 12 nM (122% efficacy relative to T0901317) in an ABCA1 mRNA induction assay in J774 mouse cells. (C) 2009 Elsevier Ltd. All rights reserved.
• [EN] NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS<br/>[FR] NOUVEAUX ESTERS DE QUINOLÉINE UTILES POUR LE TRAITEMENT DE TROUBLES CUTANÉS
  申请人：WYETH LLC

  公开号：WO2012004748A1

  公开（公告）日：2012-01-12

  Disclosed are quinoline esters of Formula (I):(I) which are useful as Liver X receptors (LXR) modulators. Pharmaceutical compositions containing quinoline esters of Formula (I) and the use of quinoline esters of Formula (I) in the safe treatment of various skin disorders are also disclosed. Methods for preparing and using quinoline esters are further described.
• Biarylether amide quinolines as liver X receptor agonists
  作者：Ronald C. Bernotas、Robert R. Singhaus、David H. Kaufman、John Ullrich、Horace Fletcher、Elaine Quinet、Ponnal Nambi、Rayomand Unwalla、Anna Wilhelmsson、Annika Goos-Nilsson、Mathias Farnegardh、Jay Wrobel

  DOI：10.1016/j.bmc.2008.12.048

  日期：2009.2

  A series of 4-(amido-biarylether)-quinolines was prepared as potential LXR agonists. Appropriate substitution with amide groups provided high affinity LXR ligands, some with excellent potency and efficacy in functional assays of LXR activity. Novel amide 4g had a binding IC50 = 1.9 nM for LXRb and EC50 = 34 nM (96% efficacy relative to T0901317) in an ABCA1 gene expression assay in mouse J774 cells, demonstrating that 4-(biarylether)-quinolines with appropriate amide substitution are potent LXR agonists (C) 2009 Elsevier Ltd. All rights reserved.
• NOVEL QUINOLINE ESTERS USEFUL FOR TREATING SKIN DISORDERS
  申请人：Bernotas Ronald Charles

  公开号：US20120010205A1

  公开（公告）日：2012-01-12

  Disclosed are quinoline esters of Formula (I): which are useful as Liver X receptors (LXR) modulators. Pharmaceutical compositions containing quinoline esters of Formula (I) and the use of quinoline esters of Formula (I) in the safe treatment of various skin disorders are also disclosed. Methods for preparing and using quinoline esters are further described.

  公开了式(I)的喹啉酯化合物，这些化合物可用作肝X受体（LXR）调节剂。还公开了含有式(I)的喹啉酯化合物的药物组合物，以及在安全治疗各种皮肤疾病中使用式(I)的喹啉酯化合物。进一步描述了制备和使用喹啉酯的方法。